Monitoring of direct oral anticoagulants plasma levels for secondary stroke prevention.
Gabriela SiedlerKosmas MachaSvenja StollJohannes PlechschmidtRuihao WangStefan T GernerErwin StrasserStefan SchwabBernd KallmünzerPublished in: Journal of thrombosis and haemostasis : JTH (2022)
Monitoring of DOAC plasma levels could help to identify patients with increased risk for stroke recurrence and should be considered for certain subgroups, including patients with high GFR.